This work was funded by grants from the National Natural Science Foundation of China (30572274) and Ministry of Science and Technology of China (2006AA02Z223) to BH. Supports from Ministry of Education of China (NCET-06-0157) to BH are also gratefully acknowledged. References 1. Hu JL, Xue YC, Xie MY, Zhang R, Otani T, Minami Y, Yamada Y, Marunaka T: A new macromolecular antitumor antibiotic, C-1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot (Tokyo) 1988, 41:1575–1579. 2. Zhen YS, Ming XY, Yu B, Otani T, Saito H, Yamada Y: A new macromolecular

antitumor antibiotic, C-1027. III. Antitumor activity. J Antibiot (Tokyo) 1989, 42:1294–1298. 3. Dedon PC, Goldberg IH: Sequence-specific double-strand breakage of DNA by neocarzinostatin involves different chemical mechanisms within a staggered cleavage site. J Biol CA-4948 chemical structure Chem 1990, 265:14713–14716.PubMed

buy AZD1390 4. Smith AL, Nicolaou KC: The enediyne antibiotics. J Med Chem 1996, 39:2103–2117.Tideglusib manufacturer CrossRefPubMed 5. Bross PF, Beitz J, Chen G, Chen XH, Duffy E, Kieffer L, Roy S, Sridhara R, Rohman A, Williams G: Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res 2001, 7:1490–1496.PubMed 6. Maeda H, Edo K, Ishida NE: Neocarzinostatin: The Past, Present, and Future of an Anticancer Drug NY: Springer-Verlag 1997. 7. Shao RG, Zhen YS: Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology. Anticancer Agents Med Chem 2008, 8:123–131.CrossRefPubMed 8. Bibb MJ: Regulation of secondary metabolism in streptomycetes. Curr Opin Microbiol 2005, 8:208–215.CrossRefPubMed 9. Champness WC: Actinomycete development, antibiotic production, and phylogeny: questions and challenges. Prokaryotic Development (Edited by: Brun YV, Shimkets LJ). Washington DC, American Society for Microbiology 2000, 11–31. 10. Fernandez-Moreno

MA, Caballero JL, Hopwood DA, Malpartida F: The act cluster contains regulatory and antibiotic export genes, direct targets for translational control by the bldA tRNA gene of Streptomyces. Cell 1991, 66:769–780.CrossRefPubMed 11. Arias P, Fernandez-Moreno aminophylline MA, Malpartida F: Characterization of the pathway-specific positive transcriptional regulator for actinorhodin biosynthesis in Streptomyces coelicolor A3(2) as a DNA-binding protein. J Bacteriol 1999, 181:6958–6968.PubMed 12. Retzlaff L, Distler J: The regulator of streptomycin gene expression, StrR, of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites. Mol Microbiol 1995, 18:151–162.CrossRefPubMed 13. Tomono A, Tsai Y, Yamazaki H, Ohnishi Y, Horinouchi S: Transcriptional control by A-factor of strR , the pathway-specific transcriptional activator for streptomycin biosynthesis in Streptomyces griseus. J Bacteriol 2005, 187:5595–5604.CrossRefPubMed 14. Bate N, Butler AR, Gandecha AR, Cundliffe E: Multiple regulatory genes in the tylosin biosynthetic cluster of Streptomyces fradiae. Chem Biol 1999, 6:617–624.